BAicalein 6-O-β-D-glucopyranoside

Catalog No. :
ACFNIK482
CAS No. :
28279-72-3
Molecular Formula :
C21H20O10
Molecular Weight :
432.38

IUPAC Name:5,7-dihydroxy-2-phenyl-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one

BAicalein 6-O-β-D-glucopyranoside structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$585.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBAicalein 6-O-β-D-glucopyranoside
IUPAC Name5,7-dihydroxy-2-phenyl-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one
MDL No.MFCD21364065
Molecular FormulaC21H20O10
Molecular Weight432.38
SMILESO=C1C=C(C2=CC=CC=C2)OC3=C1C(O)=C(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O)C(O)=C3
InChI KeyWTYYPLMAODUDGW-QOUKUZOOSA-N
SynonymBaicalein 6-O-glucoside;6-(beta-D-Glucopyranosyloxy)-5,7-dihydroxy-2-phenyl-4H-1-benzopyran-4-one;Baicalein 6-O-beta-D-glucopyranoside;6xi-D-Glucopyranosyloxy-5,7-dihydroxy-2-phenyl-chromen-4-on;5,7-dihydroxy-2-phenyl-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one;BAicalein 6-O-β-D-glucopyranoside
CAS No.28279-72-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACFNIK482 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFNIK482 route product structure diagram
    ACFNIK48228279-72-3
Inquiry

2. ACFNIK482 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFNIK482 route product structure diagram
    ACFNIK48228279-72-3
Inquiry

Comments (0)